Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
6.37
-0.34 (-5.07%)
At close: Jul 14, 2026, 4:00 PM EDT
6.44
+0.07 (1.10%)
After-hours: Jul 14, 2026, 6:27 PM EDT

ARCT Revenue

Arcturus Therapeutics Holdings had revenue of $2.06M in the quarter ending March 31, 2026, a decrease of -92.99%. This brings the company's revenue in the last twelve months to $54.71M, down -61.92% year-over-year. In the year 2025, Arcturus Therapeutics Holdings had annual revenue of $82.03M, down -46.14%.

Revenue (ttm)
$54.71M
Revenue Growth
-61.92%
P/S Ratio
3.36
Revenue / Employee
$492,883
Employees
111
Market Cap
181.05M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202582.03M-70.28M-46.14%
Dec 31, 2024152.31M-14.49M-8.69%
Dec 31, 2023166.80M-39.20M-19.03%
Dec 31, 2022206.00M193.64M1,566.79%
Dec 31, 202112.36M2.82M29.56%
Dec 31, 20209.54M-11.25M-54.12%
Dec 31, 201920.79M5.04M31.97%
Dec 31, 201815.75M2.76M21.20%
Dec 31, 201713.00M-7.38M-36.23%
Dec 31, 201620.38M14.24M232.06%
Dec 31, 20156.14M--
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Protalix BioTherapeutics76.38M
MediWound14.48M
Equillium4.39M
Cibus4.29M
Korro Bio3.84M
NRx Pharmaceuticals2.29M
Humacyte2.02M
Revenue Rankings